Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3382
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01631474 | A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris | ||
| NCT07095127 | Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia | ||
| NCT06216366 | Rhu-pGSN to Mitigate Proinflammatory Responses to Decompression in Healthy SCUBA Divers | ||
| NCT00758966 | Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder | ||
| NCT00501579 | Study of Difluprednate in the Treatment of Uveitis | ||
| NCT00515710 | LTFU for Gene Transfer Subjects With Hemophilia B | ||
| NCT02264613 | ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas | ||
| NCT04434482 | IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer | ||
| NCT00737282 | Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids | ||
| NCT05181124 | Compare Pharmacokinetics and Safety of JP-1366 Between Korean and Caucasian | ||
| NCT05089617 | To Evaluate the Safety, Tolerability, and Pharmacokinetics of YG1699（Antidiabetic） in Healthy Chinese Sbjects | ||
| NCT06742268 | Extension Study on Safety and Rebound Effect of SAT-001 for Myopia in Children | ||
| NCT04429191 | JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation | ||
| NCT05401110 | Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer | ||
| NCT03272256 | Phase 1 Study of IM156 in Patients With Advanced Solid Tumor and Lymphoma | ||
| NCT07424677 | Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy | ||
| NCT06313996 | A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular Lymphoma | ||
| NCT00616070 | Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003) | ||
| NCT00434369 | 5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients | ||
| NCT03398005 | A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1) | ||
| NCT00406341 | Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation | ||
| NCT04660929 | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | ||
| NCT04542642 | A Remote, Decentralized Opioid Use Disorder Study to Evaluate Patient Engagement With a Game-Based Digital Therapeutic | ||
| NCT00381303 | GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men. | ||
| NCT03538951 | Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis | ||
| NCT03363945 | Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants | ||
| NCT06835569 | A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations | ||
| NCT06234423 | A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors | ||
| NCT00633880 | Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) | ||
| NCT03288480 | A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma | ||
| NCT02495896 | Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors | ||
| NCT01451424 | Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids | ||
| NCT03326856 | ET-01 in Subjects With Lateral Canthal Lines | ||
| NCT01186731 | Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic Cancer | ||
| NCT01891396 | Cingal Study for Knee Osteoarthritis | ||
| NCT06068946 | VK2735 for Weight Management Phase 2 | ||
| NCT04504383 | PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC) | ||
| NCT00324194 | A Phase I Study of MGCD0103 Given Twice Weekly in Patients With Leukemia or Myelodysplastic Syndromes | ||
| NCT06146257 | A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes | ||
| NCT01521819 | Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration | ||
| NCT06181136 | Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A) | ||
| NCT07321834 | A Study to Evaluate AI-09 In Participants With Glabellar Lines | ||
| NCT03776864 | Umbralisib and Pembrolizumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma | ||
| NCT02094599 | A Study of the Abuse Potential of Dronabinol in Recreational Cannabinoid Users | ||
| NCT05812014 | Clinical Trail of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) in Participants Aged 18 Years and Older | ||
| NCT03993873 | Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET | ||
| NCT01779453 | A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia | ||
| NCT03784300 | A Safety Study of PTI-125 in Healthy Volunteers | ||
| NCT01647971 | Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma | ||
| NCT01632332 | Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer |
